✨
AI Summary
- Ireland faces a crucial HSE decision on funding Skyclarys.
- The drug treats Friedreich's Ataxia, a rare neurodegenerative condition.
- John McGuinness and Niamh Griffin discuss the implications for patients.
Guests on This Episode
John McGuinness
Irish politician · 1 podcast appearance
NG
Niamh Griffin
2 podcast appearances